Reasons for Low Adherence to Guidelines for CRM Conditions

EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity

EP: 2.Strategies for Prevention and Screening of CRM Conditions

EP: 3.The Link Between Obesity and CRM Conditions

EP: 4.Challenges in Managing Co-Morbid CRM Conditions

EP: 5.Contemporary Guidelines for CRM Conditions

Now Viewing

EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions

EP: 7.Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions

EP: 8.Educational Initiatives to Enhance Guideline Adherence in CRM

EP: 9.Addressing Gaps in CKD, T2D, and CVD Guidelines

EP: 10.Care Coordination for High-Risk CRM Patients

Video content above is prompted by the following:

• Studies indicate low adherence to guideline recommendations among patients with type 2 diabetes, ASCVD, and CKD. What are the main reasons for this low adherence?
  • How prevalent is guideline adherence within the US health systems?

This activity is supported by an educational grant from Boehringer Ingelheim.